UPDATE: AxoGen (AXGN) Reports In-Line Q1 EPS

(Updates shows adjusted EPS)

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.08 million.

Management reiterates 2018 revenue will grow at least 40% over 2017 revenue and gross margins will remain above 80%. Additionally, management now expects to have at least 80 direct sales reps by year end, compared to the previous estimate of at least 75.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Rank One Computing (ROC) Reiterated at Buy by Benchmark Post ZTC Acquisition
• 'Long-term deals significant positive for stock:' Analysts react to Micron results